Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones

Journal of Physiology

Volumn 569, Issue 2, 2005, Pages 501-517

  Straiker, Alex ^a   Mackie, Ken ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARRIER PROTEIN; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; ETHER DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM EXPOSURE; MOUSE; NERVE CELL CULTURE; NERVE CELL INHIBITION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ASTROCYTE; DEPOLARIZATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL NEURONAL CULTURE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CELLS, CULTURED; ENDOCANNABINOIDS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; GLYCERIDES; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MORPHOLINES; NAPHTHALENES; NEURONAL PLASTICITY; NEURONS; NITRIC OXIDE; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 29244449844     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.091918     Document Type: Article

References (60)

1. Alger BE (2002). Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68, 247-286.
2. Ameri A & Simmet T (2000). Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 361, 265-272.
3. Bass CE & Martin BR (2000). Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend 60, 113-119.
4. Bekkers JM & Stevens CF (1991). Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci U S A 88, 7834-7838.
5. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A & Piomelli D (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094-1097.
6. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V & Doherty P (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163, 463-468.
7. Bisogno T, MacCarrone M, De Petrocellis L, Jarrahian A, Finazzi-Agro A, Hillard C & Di Marzo V (2001). The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur J Biochem 268, 1982-1989.
8. Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ & Sim-Selley LJ (1999). Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73, 2447-2459.
9. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR & Lichtman AH (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98, 9371-9376.
10. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A & Mechoulam R (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
11. Diana MA & Marty A (2004). Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142, 9-19.
12. Franklin A & Stella N (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 474, 195-198.
13. Furshpan EJ, MacLeish PR, O'Lague PH & Potter DD (1976). Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc Natl Acad Sci U S A 73, 4225-4229.
14. Gaoni Y & Mechoulam R (1964). Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86, 1646-1647.
15. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I & Freund TF (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12, 3239-3249.
16. Hajos N, Ledent C & Freund TF (2001). Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106, 1-4.
17. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I & Mechoulam R (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A 98, 3662-3665.
18. Isokawa M & Alger BE (2005). Retrograde endocannabinoid regulation of GABAergic inhibition in the dentate gyrus granule cell. J Physiol 567, 1001-1010.
19. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V & Piomelli D (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9, 76-81.
20. Katona I, Sperlagh B, Magloczky Z, Santha E, Kofalvi A, Czirjak S, Mackie K, Vizi ES & Freund TF (2000). GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100, 797-804.
21. Kelley BG & Thayer SA (2004a). Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol 496, 33-39.
22. Kelley BG & Thayer SA (2004b). Delta9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture. Neuropharmacology 46, 709-715.
23. Kim J & Alger BE (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7, 697-698.
24. Kreitzer AC, Carter AG & Regehr WG (2002). Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34, 787-796.
25. Kreitzer AC & Regehr WG (2001a). Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21, RC174.
26. Kreitzer AC & Regehr WG (2001b). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29, 717-727.
27. Lenz RA, Wagner JJ & Alger BE (1998). N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 512, 61-73.
28. Levison SW & McCarthy KD (1991). Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors. J Neurochem 57, 782-794.
29. Lichtman AH, Shelton CC, Advani T & Cravatt BF (2004). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109, 319-327.
30. Llano I, Leresche N & Marty A (1991). Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6, 565-574.
31. Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, de Lago E, Fernandez-Ruiz J & Ramos JA (2003a). Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. Eur J Med Chem 38, 403-412.
32. Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, de Lago E, Fernandez-Ruiz J & Ramos JA (2003b). Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J Med Chem 46, 1512-1522.
33. Lu B (2003). BDNF and activity-dependent synaptic modulation. Learn Mem 10, 86-98.
34. Luk T, Jin W, Zvonok A, Lu D, Lin XZ, Chavkin C, Makriyannis A & Mackie K (2004). Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. Br J Pharmacol 142, 495-500.
35. Mackie K, Devane WA & Hille B (1993). Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44, 498-503.
36. McLaughlin JP & Chavkin C (2001). Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy. Mol Pharmacol 59, 1360-1368.
37. Marcaggi P & Attwell D (2005). Endocannabinoid signaling depends on the spatial pattern of synapse activation. Nat Neurosci 8, 776-781.
38. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C & Lutz B (2003). CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84-88.
39. Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE & Manzoni OJ (2004). A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat Neurosci 7, 585-586.
40. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC & Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
41. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G & Gessa GL (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24, 53-62.
42. Ohno-Shosaku T, Maejima T & Kano M (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738.
43. Ohno-Shosaku T, Sawada S & Yamamoto C (1997). Properties of depolarization-induced suppression of inhibitory transmission in cultured rat hippocampal neurons. Pfluger's Archiv 435, 273-279.
44. Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A & Kano M (2002). Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22, 3864-3872.
45. Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K & Sugiura T (2003). Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem 85, 1374-1381.
46. A responses in hippocampal pyramidal cells. J Neurosci 12, 4122-4132.
47. Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA & Imperato A (1999). Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379, R1-R2.
48. Ronesi J, Gerdeman GL & Lovinger DM (2004). Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24, 1673-1679.
49. Ruano D, Lambolez B, Rossier J, Paternain AV & Lerma J (1995). Kainate receptor subunits expressed in single cultured hippocampal neurons: molecular and functional variants by RNA editing. Neuron 14, 1009-1017.
50. Shen M & Thayer SA (1998). Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54, 459-462.
51. Sim LJ, Hampson RE, Deadwyler SA & Childers SR (1996). Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16, 8057-8066.
52. Stella N, Schweitzer P & Piomelli D (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
53. Sullivan JM (1999). Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 82, 1286-1294.
54. 2+-ATPase. Proc Natl Acad Sci U S A 87, 2466-2470.
55. Topham MK & Prescott SM (2002). Diacylglycerol kinases: regulation and signaling roles. Thromb Haemost 88, 912-918.
56. Trettel J, Fortin DA & Levine ES (2004). Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556, 95-107.
57. Vincent P, Armstrong CM & Marty A (1992). Inhibitory synaptic currents in rat cerebellar Purkinje cells: modulation by postsynaptic depolarization. J Physiol 456, 453-471.
58. Walter L & Stella N (2003). Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. Glia 44, 85-90.
59. Wilson RI & Nicoll RA (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
60. Witting A, Walter L, Wacker J, Moller T & Stella N (2004). P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci U S A 101, 3214-3219.